GLASSIA is a Intravenous Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .alpha.1-proteinase Inhibitor Human.
Product ID | 0944-2884_08d8f23f-5ecb-431c-bb45-0183756d7a8b |
NDC | 0944-2884 |
Product Type | Plasma Derivative |
Proprietary Name | GLASSIA |
Generic Name | .alpha.1-proteinase Inhibitor Human |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-07-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125325 |
Labeler Name | Baxalta US Inc. |
Substance Name | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
Active Ingredient Strength | 1 g/50mL |
Pharm Classes | Human alpha-1 Proteinase Inhibitor [EPC], Trypsin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2010-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125325 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2014-04-04 |
Marketing Category | BLA |
Application Number | BLA125325 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2010-07-01 |
Ingredient | Strength |
---|---|
.ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 g/50mL |
NDC | Brand Name | Generic Name |
---|---|---|
0944-2884 | GLASSIA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
0053-7202 | ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
0053-7203 | ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GLASSIA 88833225 not registered Live/Pending |
Crilamex, S.A. de C.V. 2020-03-13 |
GLASSIA 77925761 3871558 Live/Registered |
KAMADA LTD. 2010-02-02 |